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The significance of the major immediate-early gene ie3 of mouse cytomegalovirus (MCMV) and that of the
corresponding ie2 gene of human cytomegalovirus to viral replication are not known. To investigate the
function of the MCMV IE3 regulatory protein, we generated two different MCMV recombinants that contained
a large deletion in the IE3 open reading frame (ORF). The mutant genomes were constructed by the bacterial
artificial chromosome mutagenesis technique, and MCMV ie3 deletion mutants were reconstituted on a mouse
fibroblast cell line that expresses the MCMV major immediate-early genes. The ie3 deletion mutants failed to
replicate on normal mouse fibroblasts even when a high multiplicity of infection was used. The replication
defect was rescued when the IE3 protein was provided in trans by a complementing cell line. A revertant virus
in which the IE3 ORF was restored was able to replicate with wild-type kinetics in normal mouse fibroblasts,
providing evidence that the defective growth phenotype of the ie3 mutants was due to disruption of the ie3 gene.
To characterize the point of restriction in viral replication that is controlled by ie3, we analyzed the pattern of
expression of selective early (b) and late (g) genes. While we could detect transcripts for the immediate-early
gene ie1 in cells infected with the ie3 mutants, we failed to detect transcripts for representative b and g genes.
These data demonstrate that the MCMV transactivator IE3 plays an indispensable role during viral replication
in tissue culture, implicating a similar role for the human CMV ie2 gene product. To our knowledge, the ie3
deletion mutants represent the first MCMV recombinants isolated that contain a disruption of an essential gene.
Gene expression during the lytic replication cycle of cyto-
megalovirus (CMV) is, as in all herpesviruses, regulated in a
cascade fashion (27). Viral gene expression starts with the
transcription of immediate-early (IE or a) genes immediately
after infection. Transcription of IE genes is carried out by the
cellular RNA polymerase II and is not dependent on de novo
synthesis of viral proteins. Viral transactivator proteins that are
synthesized during the IE phase activate transcription of early
(b) genes and give rise to a more extended gene expression
program during the early phase of the replication cycle. Ex-
pression of late (g) genes occurs after the onset of the viral
DNA replication.
The structural organizations of the major IE gene regions of
mouse and human CMV (MCMV and HCMV, respectively)
show remarkable similarity (31). A complex regulatory se-
quence, the major IE enhancer promoter (MIEP), controls
transcription of the IE genes. Five exons are encoded down-
stream of the MIEP. The first three exons are spliced to either
exon 4, generating the ie1 transcript, or to exon 5, generating
the ie2 transcript. In HCMV, the ie1 transcript is translated
into the acidic 72-kDa IE1 phosphoprotein. The HCMV ie2
transcript gives rise to the 86-kDa IE2 phosphoprotein. The
corresponding IE transcripts of MCMV encode the 89-kDa
acidic IE1 phosphoprotein pp89 (15, 16) and the 88-kDa IE3
protein (24).
The functions of the HCMV IE proteins have been well
analyzed during recent years. Both of the major HCMV IE
proteins are involved in regulation of viral gene expression. It
has been suggested that the IE1 protein augments its own
expression by positive autoregulation of the MIEP (6, 32, 33).
IE1 also has a costimulatory function in the activation of viral
early promoters (reviewed in 31 and 27). More recently, it has
been shown that IE1 mediates the disruption of nuclear struc-
tures, the promyelocytic leukemia protein (PML)-associated
nuclear bodies or nuclear domains 10 (ND10), probably in
order to generate a favorable environment for replication of
the HCMV genome (1, 2, 13, 17). The HCMV IE2-p86 protein
is a potent transactivator of HCMV early promoters and of
heterologous viral as well as cellular promoters (reviewed in 31
and 27). It is believed that the IE2-p86 protein is the key
regulatory protein that governs early and most likely also late
gene expression of HCMV. In addition, IE2 down-regulates
transcription from its own promoter by binding to the cis-
repression signal (crs) target site near the transcription start
site of ie1/ie2, thereby mediating autoregulation of its own
expression (21, 22, 36). Recent studies suggest that the IE2
protein is also involved in blocking the cell cycle of infected
cells (35). In contrast to the thorough functional characteriza-
tion of the isolated HCMV IE2 protein that was mostly done
by transient transfection assays, little is known about its role in
the context of the viral infection. An HCMV mutant virus with
a deletion of the ie2 gene is not available yet.
Although the functions of the MCMV IE3 protein are not as
well analyzed as those of its HCMV counterpart, it is never-
theless clear that the MCMV IE3 protein plays a similar role
for replication of MCMV as the HCMV IE2 protein does for
HCMV. Namely, it activates MCMV early promoters and is
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able to repress transcription from the MCMV MIEP (5, 24).
This functional equivalence is also reflected in the conserva-
tion of the amino acid sequences between the MCMV IE3 and
the HCMV IE2 proteins. It is assumed that CMV IE proteins
have an important role not only for initiation of the lytic rep-
lication cycle but probably also during reactivation of CMV
from latency. This aspect will presumably be studied best with
MCMV mutants in the mouse model. There is indeed evidence
for episodes of ie1 transcription during latency of MCMV (12,
18, 19). It is more interesting, however, that the occurrence of
ie3 transcripts during induced reactivation was often associated
with more extended gene transcription of MCMV and with
virus recurrence (20). The availability of an MCMV ie3 mutant
offers the possibility to study the function of the IE3 protein for
growth of MCMV in tissue culture as well as its role in patho-
genesis of the MCMV infection in vivo.
Here we report on the generation and characterization of
MCMV ie3 mutants. The ie3-deficient mutants did not repli-
cate in normal mouse fibroblasts, but growth could be restored
by a complementing cell line that provided the IE3 protein in
trans. Our data show an essential regulatory function of the
IE3 protein during the lytic replication cycle of MCMV.
MATERIALS AND METHODS
Cells and viruses. Mouse NIH 3T3 cells (ATCC CRL1658) were grown in
Dulbecco’s modified Eagle medium supplemented with 10% newborn calf se-
rum. Primary mouse embryonic fibroblasts were prepared from BALB/c.ByJ
mice and grown in Dulbecco’s modified Eagle medium with 10% fetal calf serum.
The bacterial artificial chromosome (BAC)-derived MCMV strain MW97.01
(34), which we refer to as parental MCMV in this study, was propagated on NIH
3T3 cells. The ie3-deficient mutants were grown on the complementing cell line
NIH 3T3-Bam25.
Construction of NIH 3T3-Bam25 cells. NIH 3T3-Bam25 cells were derived
from NIH 3T3 cells by cotransfecting pBam25 (14) and pPUR (Clontech, Palo
Alto, Calif.), a plasmid containing the puromycin resistance gene, using the
calcium phosphate technique (10) and selecting cells in medium containing
puromycin (Sigma) at 5 mg/ml. Plasmid pBam25 contains a 10.6-kbp BamHI
fragment of the MCMV genome (nucleotides [nt] 176,441 to 187,035 [30]) and
encodes the MCMV ie1 and ie3 genes under control of the authentic MCMV
enhancer ie1/ie3 promoter (14). Cultures were re-fed every 3 to 5 days. Single
colonies were picked using cloning cylinders and analyzed for IE1 expression by
indirect immunofluorescence using monoclonal antibody Croma 101 (kindly
provided by S. Jonjic). Reverse transcription-PCR (RT-PCR) using ie1- and
ie3-specific primers was carried out to confirm the presence of the ie1 and ie3
transcripts in NIH 3T3-Bam25 cells. Several cell lines were obtained. For the
purpose of this study, we primarily used clone 23 and confirmed our results with
clone 18.
Viral growth curves. Monolayers of NIH 3T3 cells or NIH 3T3-Bam25 cells in
24-well dishes were infected at a multiplicity of infection (MOI) of 2 (for single-
cycle growth curves) or 0.05 PFU/cell (for multicycle growth curves) with the
different MCMV recombinants. After a 1-h adsorption period, cells were washed
three times with phosphate-buffered saline and fed with fresh medium. At dif-
ferent time points after infection, the supernatants of three separate cultures
were harvested, cleared of cellular debris, frozen, and thawed. Viral titers were
determined by standard plaque assays on NIH 3T3-Bam25 cells.
Plasmid construction. The recombination plasmid pSTKSie3 was constructed
to delete the ie3 gene from the BAC plasmid pSM3fr. Briefly, plasmid pSL301
(Invitrogen, Carlsbad, Calif.) was modified by insertion of an oligonucleotide
adapter providing MunI, HindIII, and NsiI sites (forward, 59-agc tgc aat tgc gaa
gct tgg atg cat cc-39; reverse; 59-aat tgg atg cat cca agc ttc gca att gc-39) into the
MunI/HindIII digested vector. A 3.1-kbp NsiI/PstI fragment (nt 175,044 to
178,117 of MCMV [30]) was isolated from plasmid HindIII K (7) and cloned into
the NsiI site of the vector resulting in plasmid pCBie3. A 3.2-kbp HindIII/MunI
fragment (equivalent to MCMV nt 179,510 to 182,682 [30]) was excised from
pp89UC (24) and integrated between the HindIII and MunI sites of pCBie3,
resulting in plasmid pp89.4. The complete insert was then transferred as a
6.3-kbp NsiI/MunI fragment into the shuttle plasmid pST76KS11, a derivative of
pST76KSacB (4) that encodes the negative selection marker sacB (9).
For insertion of the green fluorescent protein (GFP) marker into the MCMV
BAC plasmid, the recombination plasmid pST76KS-GFP was generated. Plasmid
pUCH3L, comprising the MCMV HindIII L fragment (7), was digested with
HpaI, which released a 79-bp fragment (nt 184,236 to 184,315 [30]). An oligo-
nucleotide adapter (forward, 59-ggg atg cat tag ttt aaa cgg cgc gcc-39; reverse,
59-ggc gcg ccg ttt aaa cta atg cat ccc-39) was inserted that provided the restriction
enzyme sites NsiI and AscI, resulting in plasmid pHMM5. The polylinker of
plasmid pEGFP-C1 (Clontech) was removed by digestion with BamHI and BglII
followed by religation. Then a 1.6-kbp NsiI/MluI fragment comprising the
HCMV MIEP, the GFP open reading frame (ORF), and the simian virus 40
polyadenylation signal was excised from the modified pEGFP-C1 plasmid and
inserted between the NsiI and AscI sites of pHMM5. A 7.2-kbp MscI/BamHI
fragment was excised and transferred to shuttle plasmid pST76KSacB (4).
For construction of a revertant virus genome, recombination plasmid
pST76KSie3rev was made as follows; plasmid pp89.4 was digested with NsiI and
HindIII, and a 5.7-kbp NsiI/HindIII K fragment (MCMV nt 175,044 to 180,728
[30]) representing the genomic MCMV ie3 sequence was inserted. Then the
complete NsiI/MunI insert (equivalent to MCMV nt 175,044 to 182,682 [30]) was
transferred to the shuttle vector pST76KS11.
BAC mutagenesis and reconstitution of MCMV mutants. Recombination be-
tween the shuttle plasmids and the MCMV BAC plasmid pSM3fr (34) was
performed by a two-step replacement procedure in the Escherichia coli strain
CBTS as first described by O’Connor et al. (28) utilizing the recently described
modifications (3, 4, 34). Recombinant viruses were reconstituted by transfection
of the BAC plasmids into murine embryonic fibroblasts, NIH 3T3, or the com-
plementing cell lines using the calcium phosphate transfection method.
Viral nucleic acid isolation and analysis. Preparation of total DNA from
infected cells, restriction enzyme analysis, and gel electrophoresis was essentially
done as described previously (3). MCMV BAC plasmids were isolated from
400-ml E. coli cultures by using Nucleobond PC 500 columns (Macherey-Nagel,
Du¨ren, Germany) according to the instructions of the manufacturer.
RT-PCR. NIH 3T3 cells or NIH 3T3-Bam25 cells were infected with the
different recombination viruses at an MOI of 0.5 PFU/cell. For selective expres-
sion of IE transcripts, the cultures were incubated from 30 min prior to infection
to 13 h postinfection (p.i.) in the presence of cycloheximide (100 mg/ml; Sigma).
Total RNA was isolated at the indicated time points after infection by using the
RNAzol B method (Tel-Test, Inc., Friendswood, Tex.) according to the manu-
facturer’s protocol. RNA samples were treated with RNase-free DNase I for 15
min at room temperature, and the DNase was inactivated at 65°C for 15 min. The
RNA was reverse transcribed using oligo(dT) primers at 42°C for 50 min, and
reactions were terminated by heating at 70°C for 15 min. The reverse transcribed
products were treated with RNase H for 20 min at 37°C and amplified using
specific primers. Primers ie1-R (59-tac agg aca aca gaa cgc tc-3’) and ie1/ie3-F
(59-cct cga gtc tgg aac cga aa-39) were used to amplify a 188-bp product within the
ie1 gene, primers ie3-R (59-tgt gag gca gta gtt ata cc-39) and ie1/ie3-F were used
to amplify a 299-bp fragment within the ie3 gene, primers gB-R (59-aga atg tca cgt
gcg act gg-39) and gB-F (59-gca cgt cgt agg taa att gc-39) were used to amplify a
509-bp region within the gB gene, and primers HPRT-R (59-aga ttc aac ttg cgc tca
tct tag gc-39) and HPRT-F (59-ttg gat aac agg cca gaa ctt tgt tgg-39) were used to
amplify a 163-bp product within the hypoxanthine phosphoribosyltransferase
(HPRT) cellular gene. These primer sets have been previously described (18, 19).
Primers M54C (59-cga gtt cgt tca cgt ttc cac ag-39) and M54NC (59-gat atg caa gaa
gag gta tat cg-39) were designed to amplify a 660-bp product within the MCMV
M54 gene. Primers M115C (59-atc ttg atc tgg tcg ctg act ga-39) and M115NC
(59-gac ctc acc acc gta tac gtg tta-39) were designed to amplify a 679-bp product
within the M115 gene. PCRs were performed under the following conditions: 1
cycle at 94°C for 3 min; 30 cycles of 1 min at 94°C, 1 min at the corresponding
annealing temperature, and 1 min at 72°C; and 1 cycle at 72°C for 10 min.
Annealing temperatures were as follows: 51°C for the M115-specific primers,
58°C for the ie1, ie3, gB, and HPRT primers, and 60°C for the M54-specific
primers. The presence of introns in the viral ie1 and ie3 genes and the cellular
HPRT gene made it possible to distinguish the correct amplified RNA from
contaminant viral or cellular DNA by its size. In the case of the gB, M54, and
M115 genes lacking introns, amplificates derived from RNA and DNA could not
be distinguished by size. Control reactions carried out in the absence of reverse
transcriptase were used to assess the specific detection of RNA. Amplified
products were separated on a 1% agarose gel and visualized by ethidium bromide
staining.
RESULTS
Construction of MCMV genomes with a deletion in the IE3
ORF. All functions described so far for the MCMV IE3 pro-
tein have been deduced from data that were obtained with
transient transfection experiments (24). To examine the func-
tion of IE3 during the replication cycle of MCMV, we gener-
ated MCMV mutants with a deletion in the IE3 ORF. Con-
struction of the mutant genomes was performed by using the
recently established BAC mutagenesis procedure (25, 34). The
MCMV BAC plasmid pSM3fr (34; Fig. 1, line 1) represents the
parental genome that was used to construct the ie3 deletion
genomes. pSM3fr contains the complete MCMV genome
cloned into a BAC vector. After transfection into permissive
cells, it gives rise to recombinant MCMV whose growth prop-
erties are indistinguishable from wild-type (wt) MCMV (34).
In order to disrupt the IE3 ORF, a 1.4-kbp deletion was in-
11130 ANGULO ET AL. J. VIROL.
troduced into the cloned MCMV genome by making use of the
recombination procedures in E. coli as described in Materials
and Methods. The deletion (nt 178,117 to 179,510 of the
MCMV genome [30]) removed almost entirely the fifth exon of
the MCMV ie1/ie3 transcription unit (see Fig. 1, line 2). Thus,
the MCMV genome of BAC plasmid pSM3frdie3 was unable
to encode the IE3 protein. The position of the deletion in the
BAC plasmid pSM3frdie3 was tagged with a HindIII restriction
enzyme site (Fig. 1, line 2) in order to facilitate the character-
ization of the mutant genome. In a second step, the green
fluorescent protein (GFP) reporter gene under control of the
HCMV MIEP was introduced into the ie3-deficient genome,
resulting in BAC plasmid pSM3frdie3::GFP (Fig. 1, line 3).
The GFP expression cassette was inserted in front of the ie2
gene (26) since it was previously shown that foreign genes can
be inserted at this location without affecting the growth of the
recombinant MCMV (23). Insertion of the GFP gene was
performed with the intention to follow replication of the ie3-
deficient genome in transfected cells by monitoring GFP ex-
pression. Finally, we generated a revertant genome by restor-
ing the IE3 ORF. The revertant genome pSM3fr-rev was made
to test whether the phenotype of the ie3 knock-out mutants
was caused solely by disruption of the ie3 gene. The revertant
genome also contained the GFP gene and could therefore be
distinguished from the genome of the parental virus (Fig. 1,
compare lines 1 and 4).
The structure of the BAC plasmids was analyzed by diges-
tion of plasmid DNA with restriction enzyme HindIII followed
by agarose gel electrophoresis (Fig. 2). The 7.6-kbp HindIII K
fragment of the parental BAC plasmid pSM3fr was missing in
the BAC plasmid pSM3frdie3 and was replaced by two new
fragments of 1.2 and 4.9 kbp (Fig. 1, lines 1 and 2; Fig. 2,
compare lanes 1 and 2). Insertion of the GFP expression cas-
sette in BAC plasmid pSM3frdie3::GFP resulted in a shift of
the 7.2-kbp HindIII L fragment to a new fragment of 8.8 kbp
(Fig. 1, lines 2 and 3). Hence, the 7.2-kbp HindIII fragment
disappeared in the DNA of BAC plasmid pSM3frdie3::GFP,
and a new band of 8.8 kbp was observed (Fig. 2, lane 3).
Restoration of the ie3 gene led to the reappearance of the
7.6-kbp HindIII K fragment in the revertant BAC plasmid
pSM3fr-rev (Fig. 2, lane 4). Additional characterization of the
ie3-deficient BAC plasmids was performed by digestion with
restriction enzymes EcoRI and NsiI. The observed DNA pat-
terns of the BAC plasmids were as expected (data not shown).
These results show that the intended modifications were intro-
duced in the MCMV BAC plasmids and that no adventitious
deletions or rearrangements could be detected anywhere else
in the cloned genomes.
FIG. 1. Construction of ie3-deficient MCMV BAC genomes. The HindIII map of the MCMV genome is shown at the top. The expanded map of the HindIII K and
L fragments represents the major IE gene region of MCMV. Coding exons are shown in black, and the first noncoding exon of the ie1/ie3 transcription unit is depicted
as an open rectangle. The gray box marks the MCMV enhancer ie1/ie3 promoter. The structure of the ie1 and ie3 transcripts is indicated below line 1 of the expanded
map. Starting with the parental MCMV BAC plasmid pSM3fr (line 1), the other BAC plasmids pSM3frdie3 (line 2), pSM3frdie3::GFP (line 3), and pSM3fr-rev (line
4) were generated by successive rounds of homologous recombination in E. coli as described in Materials and Methods. The deletion in the fifth exon of the ie3 gene
is marked by the delta (D). The cross-hatched box in front of the GFP ORF represents the HCMV MIEP.
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The ie3 gene is essential for viral DNA infectivity. To test
whether the ie3 gene is essential for infectivity, the MCMV
BAC plasmids were transfected into NIH 3T3 cells that are
permissive for MCMV infection. The results of the experi-
ments are shown in Table 1. Transfection of the parental BAC
plasmid pSM3fr and of the revertant BAC plasmid pSM3fr-rev
reproducibly resulted in the formation of plaques. Plaques
occurred usually around day 4 or 5 posttransfection, and the
infection spread rapidly throughout the monolayers. Cells har-
boring the revertant virus genome displayed a green fluores-
cence due to expression of GFP. Transfection of the ie3-defi-
cient genomes pSM3frdie3 and pSM3frdie3::GFP into NIH
3T3 cells did not lead to plaque formation. Identical results
were obtained after transfection of the BAC plasmids into
mouse embryonic fibroblasts (data not shown). These results
suggested that the ie3 gene is essential for the lytic replication
cycle of MCMV.
In a first attempt to prove that the failure of the ie3-deficient
BAC plasmids to form plaques was due to the disrupted ie3
gene, we performed rescue experiments by cotransfection of
plasmid pBam25. pBam25 spans the deleted region and en-
codes the MCMV IE proteins IE1 and IE3 (15, 24). After
cotransfection, pBam25 provides the missing IE3 protein in
trans, to initiate the MCMV replication cycle. Recombination
between the plasmid and the ie3-deficient genomes may even-
tually result in the reconstitution of replication-proficient ge-
nomes. The results of this experiment are shown in Table 1
(second line). The infectivity of BAC plasmids pSM3fr and
pSM3fr-rev was not influenced by cotransfection of plasmid
pBam25. A few plaques appeared after cotransfection of the
ie3-deficient BAC plasmids and pBam25. Typically, the
plaques were first seen at 7 to 8 days posttransfection. After
occurrence of the plaques, the infection spread rapidly
throughout the tissue culture. Infected cells in the culture
transfected with BAC plasmid pSM3frdie3::GFP displayed a
green fluorescence. The reduced number of plaques as well as
the delayed kinetics in plaque formation was consistent with
the expectation that reconstitution of replication-proficient ge-
nomes by recombination with the complementing plasmid had
to occur prior to plaque formation. Analysis of viral DNA
obtained from these cultures showed that the reconstituted
viruses had indeed acquired the ie3 gene from the cotrans-
fected plasmid (data not shown). Altogether, these experi-
ments indicated that the ie3-deficient MCMV genomes cannot
give rise to infectious virus in normal murine fibroblasts and
that the replication-deficient genomes can be rescued by co-
transfection of a complementing plasmid.
trans-complementation of viral DNA infectivity and recon-
stitution of MCMV ie3 mutants. Since the ie3 gene seemed to
be essential for replication of MCMV, a complementing cell
line that provided the missing IE3 protein in trans was needed
in order to reconstitute mutant viruses from the recombinant
BAC plasmids. To this end, NIH 3T3 cells were transfected
with plasmid pBam25 that encodes the MCMV IE genes ie1
and ie3, and stable NIH 3T3-Bam25 cell lines were isolated as
described in Materials and Methods.
The four different BAC plasmids were then transfected into
one of the NIH 3T3-Bam25 cell lines. Plaques appeared
around 5 to 7 days posttransfection, and the infection spread
throughout the culture. To analyze the genome structure of the
reconstituted mutants, viral DNA was isolated from infected
NIH 3T3-Bam25 cells and subjected to restriction enzyme di-
gestion. Fig. 3 shows the DNA fragment profiles after HindIII
digestion of the four different MCMV genomes. The DNA
patterns of the viral genomes were identical to those of the
corresponding BAC plasmids (compare Fig. 2 and 3), confirm-
ing that the viral mutants were reconstituted from these BAC
plasmids and that the viral genomes did not change during
replication in the complementing cell line. These data demon-
strate that the cell line was able to support replication of the
ie3-deleted genomes and growth of the ie3-deficient MCMV
mutants.
Growth analysis of the ie3 mutants. The possibility to prop-
agate the ie3 mutants on the complementing cell line allowed
us to prepare viral stocks. Thus, we could then perform infec-
tion experiments with the mutant viruses and test whether the
ie3 gene is definitely required for growth of MCMV in normal
mouse fibroblasts. When NIH 3T3 cells were infected with a
FIG. 2. Structural analysis of the ie3-deficient MCMV BAC genomes.
Ethidium bromide-stained agarose gel of HindIII-digested BAC plasmids
pSM3fr (lane 1), pSM3frdie3 (lane 2), pSM3frdie3::GFP (lane 3), and pSM3fr-
rev (lane 4) after separation on a 0.7% agarose gel. The names of the MCMV
HindIII fragments (7) and the sizes of the molecular-weight markers are shown
in the left and right margin, respectively. New fragments in the BAC plasmids are
marked with white arrows.
TABLE 1. Plaque formation on NIH 3T3 cells after transfection of
the MCMV BAC plasmids in the absence or presence of pBam25a
Transfection
condition
Plaque formation after transfection of BAC plasmid:
pSM3fr pSM3frdie3 pSM3frdie3::GFP pSM3fr-rev
BAC plasmid only 111 2 2 111
Cotransfection of
BAC plasmid
and pBam25b
111 1 1 11
a Scoring of the transfections was as follows: 111, 10–20 plaques; 11, 5–10
plaques; 1, 1–5 plaques; 2, no plaques.
b Plasmid pBam25 spans the deletion in the ie3-deficient BAC plasmids and
encodes the MCMV IE genes ie1 and ie3.
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low MOI of 0.05 PFU/cell, the amount of virus that could be
found in the supernatant of cultures infected with the ie3
mutant dropped below the detection level by 1 day p.i. Even 1
week p.i., viral progeny was not obtained in these cultures (Fig.
4A). Cultures that were infected with the parental MCMV
strain displayed a rapid increase in the viral titers. The growth
kinetics of the revertant virus MCMVrev were comparable to
those of the parental virus, demonstrating that reinsertion of
the ie3 gene led to a complete rescue of the growth phenotype
(Fig. 4A). This experiment indicated that the ie3 gene is es-
sential for replication of the MCMV when a low-input dose is
used. Still, it was possible that the requirement for ie3 could be
overcome by using a high MOI. To examine the growth de-
pendence of the mutant viruses on the input dose, infection
experiments were performed by using an MOI of 2. Again, no
growth of the ie3 mutants was observed when cells were in-
fected under these conditions. In contrast, the viruses that
encode the IE3 protein rapidly grew to high titers (Fig. 4B).
We concluded from these experiments that the ie3 gene is
absolutely essential for growth of MCMV in normal fibroblast
cells, regardless whether a low- or a high-input dose is used.
Growth analyses were next performed on the NIH 3T3-
Bam25 cell line to examine the growth behavior of the ie3
mutants and the capability of the complementing cell line to
support replication of the mutants. When NIH 3T3-Bam25
cells were infected with the ie3 mutants at a low MOI of 0.05
PFU/cell, virus production could be detected at 3 days p.i., and
a rise of the virus titers was observed on days 4 to 5 p.i. (Fig.
4C). The increase in the titers of the ie3 mutants was reduced
in comparison to the titers of the parental virus. Maximal titers
were obtained at day 5 p.i. with values of about 4 3 104 to 1 3
105 PFU/ml, while the ie3-expressing viruses achieved titers of
about 4.2 3 106 PFU/ml. Similar observations were made when
the NIH 3T3-Bam25 cells were infected at an MOI of 2 (Fig.
4D). Virus progeny was found 2 and 3 days p.i., but there was
little further increase of the titers after day 3 p.i. The titers that
were achieved with the parental and revertant viruses were
about 1 to 1.5 orders of magnitude higher than those obtained
with the ie3 mutants. The difference between the titers of
parental MCMV and ie3 viruses was already seen on days 2
and 3 p.i. (Fig. 4D). Altogether, these data clearly indicate that
the complementing cell line was able to support growth of the
ie3 deletion mutants, although the growth behavior of the
mutants was altered in comparison to wt virus.
The ie3 gene product is essential for early gene expression.
Next, we asked at which stage the viral gene expression was
blocked when cells were infected with the ie3 mutants that are
unable to express the regulatory protein IE3. Expression of
representative viral genes was analyzed by RT-PCR using
RNA that was isolated from cells infected with the ie3 deletion
mutant MCMVdie3::GFP and, for comparison, RNA that was
with the parental MCMV. First, we tested whether the IE
genes were transcribed when cells were infected in the pres-
ence of cycloheximide, i.e., in the absence of de novo protein
synthesis. Transcripts arising from the ie1 and ie3 genes were
FIG. 3. Structural analysis of the genomes of the MCMV ie3 mutants. DNA
isolated from NIH 3T3-Bam25 cells infected with the parental MCMV (lane 1),
the ie3-deficient mutants MCMVdie3 (lane 2), and MCMVdie3::GFP (lane 3),
or the revertant virus MCMVrev (lane 4) was subjected to HindIII digestion,
separated on a 0.7% agarose gel, and stained with ethidium bromide. Size
markers are shown in the right margin, and the names of the HindIII fragments
(7) are indicated in the left margin. New fragments in the genomes of the MCMV
mutants are marked by white arrows.
FIG. 4. Growth curve analysis of the MCMV ie3 mutants. NIH 3T3 (A, B) or
NIH 3T3-Bam25 (C, D) cells were infected at an MOI of 0.05 (A, C) or 2 PFU
per cell (B, D) with the parental MCMV, MCMVdie3, and MCMVdie3::GFP
and the revertant MCMVrev. At the indicated time points after infection (days
p.i. [dpi]), supernatants from the infected cultures were harvested and titered on
monolayers of NIH 3T3-Bam25 cells. The limit of detection was 20 PFU/ml.
Error bars indicate the standard deviation from three separate cultures.
VOL. 74, 2000 MCMV ie3 MUTANTS 11133
detected in cells infected with the parental virus (Fig. 5, lane
2). In cells infected with the ie3 mutant MCMVdie3::GFP, only
ie1 transcripts could be detected (Fig. 5, lane 4). As expected,
transcripts of IE genes accumulated under this condition of
infection because transcription of IE genes was performed by
the transcription machinery of the cell, and de novo synthesis
of viral proteins was not required. Transcription of early and
late genes did not occur since viral transactivator proteins that
were required for early and late gene expression were not
synthesized in the presence of cycloheximide. The data clearly
indicate that the ie3 mutant did not synthesize an ie3 transcript
(Fig. 5, lane 4). This result confirmed that the ie3 gene had
been disrupted in the ie3 mutant and that the mutant was
therefore unable to encode the regulatory IE3 protein.
Next, we examined the viral gene expression at 13 h p.i., a
time point during the early phase of the infection cycle well
before the onset of viral DNA replication (14; Fig. 5, lanes 1
and 3). In addition to the ie1 and ie3 transcripts, we found
transcripts of the early gene M54, encoding the viral DNA
polymerase (8) and a small amount of the transcript encoding
the glycoprotein B (M55 [29, 30]) in MCMV-infected cells
(Fig. 5, lane 1). In cells infected with the ie3 mutant, viral gene
expression was restricted to the ie1 gene (Fig. 5, lane 3). The
level of ie1 transcripts in cells infected with the ie3 mutant
seemed higher than in cells infected with the parental virus
(Fig. 5, compare lanes 1 and 3). This might indicate that feed-
back regulation of IE gene expression by the IE3 protein that
leads to reduced levels of ie1 transcripts in MCMV-infected
cells during the early phase (Fig. 5, lane 1) cannot occur in cells
infected with the ie3 mutant and results in enhanced expression
of the ie1 gene (Fig. 5, lane 3). Transcripts of early genes could
not be detected in MCMVdie3::GFP-infected cells by 13 h p.i.
(Fig. 5, lane 3). This result indicated that either activation of
early gene transcription was completely impossible in cells
infected with the ie3 mutants or the time course of the viral
gene expression program was delayed.
To distinguish between these possibilities, RNA isolated in
the late phase of the infection cycle (20 h p.i.) was analyzed.
RNA from MCMV-infected cells contained transcripts of the
late gene M115 encoding glycoprotein L (37), in addition to
the early and IE transcripts that were already detected at the
earlier time point. Again, in RNA isolated from cells infected
with the ie3 mutant, only transcripts arising from the ie1 gene
could be detected (Fig. 5, lane 6). Thus, gene expression in
MCMVdie3::GFP-infected cells was always restricted to the IE
gene ie1, irrespective of whether the cells were infected in the
presence or absence of CH and at which time point p.i. the
infected cells were analyzed (Fig. 5, compare lanes 3, 4, and 6).
Accordingly, the protein encoded by the ie3 gene must exert a
key function in activation of early gene expression.
To test directly whether ie3 is important for activating early
genes, we analyzed RNA isolated from the complementing
NIH 3T3-Bam25 cell line that had been infected with the ie3
mutant. Since the complementing cell line encodes the missing
protein, the expression of early and late genes should be re-
stored if the protein mediates the proposed regulatory func-
tion. The results of the experiment revealed the same profile of
early and late viral transcripts in MCMVdie3::GFP-infected
NIH 3T3-Bam25 cells as in MCMV-infected NIH 3T3 cells
(Fig. 5, compare lanes 7 and 5). We concluded from these
experiments that the complementing cell line provided a suf-
ficient amount of the transactivating protein to achieve activa-
tion of early and late gene expression and to substitute for the
lack of ie3 expression by the ie3 mutant. In summary, the data
indicate that the protein encoded by the ie3 gene plays an
essential role for the activation of the viral gene expression
program.
DISCUSSION
In this study, we report on the generation of MCMV ie3-
deficient mutants. Disruption of the ie3 gene on the cloned
MCMV genome was achieved by utilizing the recently estab-
lished BAC mutagenesis procedure. Transfection of ie3-defi-
cient genomes into permissive cells did not result in plaque
formation, indicating that the genomes were replication defi-
cient. Infectious viruses could be reconstituted by transfection
of the ie3-deficient genomes into a cell line that provided the
missing IE protein in trans. The ie3 mutants could not grow on
normal non-complementing cells, indicating the essential func-
tion of the ie3-encoded protein. Transcript analysis in cells
infected with an ie3 mutant showed that early and late genes
were not activated. Altogether, these data provided direct ev-
idence for an essential regulatory role of ie3 for replication of
MCMV.
Construction of MCMV ie3-deficient mutants by the BAC
technique. The mutant MCMV genomes were constructed by
site-directed mutagenesis of the cloned MCMV genomes in E.
coli (25, 34). This technique might be especially useful for
mutagenesis of essential genes since construction of the mu-
tant genome is completely independent of the ability of the
corresponding mutant virus to grow in cell culture. Thus, we
can first manipulate any gene of interest on the cloned ge-
nome, and, in a second separate step, we can examine the
phenotypic consequences of the manipulation, e.g., whether
the deleted gene is essential or nonessential.
The mutant BAC plasmids isolated from bacterial cultures
were of clonal origin. Therefore, after transfection of the BAC
FIG. 5. Detection of viral transcripts after infection with an MCMV ie3
mutant. NIH 3T3 (lanes 1 through 6) or NIH 3T3-Bam25 (lane 7) cells were
infected at an MOI of 0.5 PFU per cell with parental MCMV (lanes 1, 2, and 5)
or MCMVdie3::GFP (lanes 3, 4, 6, and 7) in the presence (lanes 2 and 4) or
absence (lanes 1, 3, and 5 to 7) of cycloheximide. Whole-cell RNA was harvested
at 13 h p.i. (lanes 1 through 4) or 20 h p.i. (lanes 5 through 7), treated with
DNase, and reverse transcribed using oligo(dT). PCRs were performed using
primer sets specific for ie1, ie3, M54, M55, M115, and HPRT as described in
Materials and Methods. Amplified products were separated on 1.5% agarose gels
and visualized by ethidium bromide staining. Sizes of the amplified products are
indicated by arrows. Specific PCR-amplified products were not detected in con-
trol reactions in which the reverse transcriptase was not added during the RNA
reverse transcription reaction (data not shown).
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plasmids into the complementing cell line, we got mutant vi-
ruses only, and no selection against parental virus was re-
quired. We consider this a major advantage of our technique in
comparison to conventional recombination techniques in com-
plementing cell lines, because selection and isolation of mutant
viruses might be quite cumbersome if the mutant has an im-
paired growth potential, in comparison to the wt virus.
Furthermore, we demonstrated that consecutive rounds of
mutagenesis can be performed on the cloned MCMV genome
without the need to reconstitute viral intermediates. We
showed that intermediate steps can lead to replication-defi-
cient genomes and that eventually a revertant replication-pro-
ficient genome can be reconstituted. The GFP marker inserted
into the revertant genome allowed us to differentiate between
the parental and the revertant viruses. Rescue of the growth
potential by reinsertion of the ie3 gene in the revertant genome
confirmed that the observed growth deficit of the ie3 mutants
was indeed due to the disruption of the ie3 gene and excluded
the possibility that any other mutation that may have been
accidentally introduced somewhere else in the genome might
have been responsible for the phenotype. To our knowledge,
this is the first report on the generation and complementation
of an MCMV mutant with a disruption of an essential gene.
Properties of the complementing cell line. The MCMV ie3
mutants could be reconstituted and propagated on NIH 3T3-
Bam25 cell lines. Neither the successful generation of the com-
plementing cell line nor the fact that the cell line was able to
support growth of the ie3 mutants seems to be trivial. For
example, several IE proteins of other herpesviruses turned out
to be toxic for cells (11). Accordingly, construction of cell lines
expressing such IE proteins was difficult. Since it has been
reported that the HCMV IE2 protein, which is homologous to
the MCMV IE3 protein, is able to block the cell cycle in
transfected cells (35), one could expect that generation of
MCMV IE3-expressing cell lines may be rather complicated.
As is observed with coexpressing ie1 and ie2 of HCMV (A.
Angulo and P. Ghazal, unpublished results), we did not en-
counter any problems in generating the NIH 3T3-Bam25 cell
lines that express both of the MCMV major IE genes. Also, we
reported before on the successful generation of a similar cell
line that encodes the MCMV IE1 and IE3 proteins (5). How-
ever, this particular cell line failed to complement the ie3
mutants. The reason for this is unclear at present but may be
the result of inappropriate expression or modification of the
MCMV major IE proteins.
The IE3 protein expressed by the complementing cell line
was sufficient to allow growth of the ie3 mutants. However, the
titers of the ie3 mutants obtained on the cell line did not reach
those levels which were achieved with the parental and rever-
tant viruses. The titers of the different viruses were determined
on the complementing cell lines, and we have to consider that
the efficiency of plaque formation of the ie3 mutants might be
lower than that of the parental virus. Although we do not have
any indication for a reduced efficiency of plaque formation, we
cannot completely rule out that the titers of the ie3 mutants
were underestimated. But even if the input titers were under-
estimated, the results indicate that the ie3 mutants grow to
lower final titers. There are several possible explanations for
the altered growth kinetics of the ie3 mutants on the comple-
menting cell line. First, the amount of the IE3 protein in the
cell line might not be as high as that during infection with wt
viruses. Second, the amount of IE3 required may vary during
the infection cycle. There is indeed evidence that the IE3
protein autoregulates expression from its own promoter (24).
Though the IE genes in the complementing cell line were
expressed from their authentic promoter, it is not clear
whether correct transcriptional regulation is maintained when
the viral genes are integrated into the cellular chromatin.
There is also evidence for posttranslational modification of the
MCMV IE3 protein during the replication cycle, most likely by
phosphorylation (24). We do not know whether appropriate
modification of IE3 occurs in the complementing cell line.
Finally, the copy number of the viral genomes goes up during
replication, whereas the number of integrated IE genes in the
cellular genomes remains constant. The lower titers of the ie3
mutants in the complementing cell line can be easily explained
if a certain amount of IE3 protein is required per viral genome.
In this case, IE3 will become limiting in the cell line when the
viral copy number increases. Accordingly, virus production will
already cease at lower titers. This will not happen when IE3 is
expressed from the wt genomes since the copy number of the
ie3 gene increases coordinately with the increase of the viral
genomes. Additional experiments are required to explain the
limited growth of the ie3 mutants in the complementing cell
line.
The ie3 gene is essential for viral growth, and the ie3 en-
coded protein is a key regulator for early gene expression. We
provide several lines of evidence that the MCMV ie3 gene is
essential for viral growth. (i) MCMV BAC genomes with a
large deletion in the ORF encoding the IE3 protein were
unable to generate viral progeny. (ii) Viral infectivity could be
restored in cis by cotransfection of a plasmid spanning the
deleted region and in trans by transfection of the BAC plas-
mids into a complementing cell line that provided the missing
IE protein. (iii) The ie3 mutants that were reconstituted on the
complementing cell line were unable to grow on normal fibro-
blasts either at low or high MOI.
During the IE phase of the infection cycle MCMV expresses
at least two proteins that are encoded by the major IE region,
namely the 89-kDa protein pp89 and the 88-kDa protein IE3.
Due to disruption of exon 5 of the ie1/ie3 transcription unit, it
is clear that the ie3 mutants are unable to express the IE3
protein. The ie1 gene is not affected by the deletion, and the
RNA analyses indicated that the ie3 mutants express ie1 tran-
scripts in infected cells irrespective of whether infection oc-
curred in the presence or absence of cycloheximide. Though
enhanced expression of the IE1 protein might occur in cells
infected with the ie3 mutants because the lack of IE3 protein
might lead to a failure in autoregulation of IE transcription
(24), we consider it unlikely that the observed growth pheno-
type is due to altered IE1 expression. This belief is supported
by the fact that disruption of the ie1 gene does not result in a
lethal phenotype (25 and unpublished data). The most likely
explanation for the growth defect of the ie3 mutants is their
inability to synthesize the IE3 protein. This conclusion is fur-
ther supported (i) by the observation that the complementing
cell line that provides the IE3 protein in trans allows growth of
the ie3 mutants and (ii) by the fact that repair of the IE3 ORF
in the revertant virus rescued the growth potential.
The restricted viral gene expression profile displayed by the
ie3 mutants is explained best by the absence of the regulatory
function of the IE3 protein. Transcription of viral genes was
confined to ie1, which can occur in the absence of viral regu-
latory proteins. Though our RNA analyses were limited to the
important early genes encoding the viral DNA polymerase and
the glycoprotein B and we cannot completely rule out that
some early genes might be activated in the absence of the IE3
protein, it seems that gene expression by the ie3 mutants is
blocked at the IE stage of the infection cycle. Accordingly, the
IE3 protein has a key regulatory function for activation of viral
gene expression, i.e., for the switch from a to b gene expres-
sion. Further studies are required to investigate whether the
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IE3 protein is just needed to initiate early gene activation or is
required throughout the replication cycle in order to maintain
viral gene expression.
The observation of the important regulatory function of the
IE3 protein has two implications. If the counterpart of the
MCMV IE3 protein in HCMV, IE2, possesses a similar key
regulatory function, it may be possible to combat the HCMV
infection by developing and using therapeutic compounds that
interfere with this function of the HCMV IE2 protein. Second,
gene activation by CMV IE proteins might represent a bottle-
neck not only during initiation of the lytic replication cycle but
also during reactivation of CMV from latency. Indeed, data
from Reddehase et al. suggest that the regulatory function of
the IE3 protein is also pivotal during reactivation of MCMV
(20). Again, this promises to offer a point of intervention at
which to inhibit recurrence of CMV and to control the CMV
infection at a very early stage.
In conclusion, we have shown that the ie3 gene plays a key
role for activation of MCMV gene expression. Given the many
similarities between the MCMV IE3 and the HCMV IE2 pro-
tein, the data of our experiments predict a comparable essen-
tial role of the IE2 protein for gene expression of HCMV
during the lytic replication cycle. The precise mechanism(s)
and functional significance of the major IE transactivator of
CMV in promoting lytic replication in vitro and in vivo are
topics that remain to be explored.
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